Table 2 Baseline comorbidity incidence compared between groups for use in multiple linear regression analysis
18.5–25 kg/m2 | 25.01–30 kg/m2 | 30.01–40 kg/m2 | > 40 kg/m2 | P-value | |
|---|---|---|---|---|---|
Myocardial Infarction | 5 (1.4%) | 37 (3.7%) | 28 (1.8%) | 12 (3.3%) | 0.009 |
Congestive Heart Failure | 8 (2.2%) | 30 (3%) | 57 (3.6%) | 16 (4.4%) | 0.317 |
Peripheral Vascular Disease | 17 (4.7%) | 80 (7.9%) | 116 (7.4%) | 31 (8.5%) | 0.152 |
Cerebrovascular Disease | 35 (9.6%) | 101 (10%) | 110 (7%) | 20 (5.5%) | 0.008 |
Dementia | 2 (0.5%) | 7 (0.7%) | 6 (0.4%) | 0 (0%) | 0.372 |
Chronic Pulmonary Disease | 60 (16.5%) | 179 (17.7%) | 277 (17.7%) | 94 (25.7%) | 0.003 |
Rheumatic Disease | 30 (8.2%) | 74 (7.3%) | 109 (7%) | 19 (5.2%) | 0.407 |
Peptic Ulcer Disease | 11 (3%) | 34 (3.4%) | 50 (3.2%) | 8 (2.2%) | 0.755 |
Mild Liver Disease | 15 (4.1%) | 42 (4.2%) | 84 (5.4%) | 29 (7.9%) | 0.041 |
Severe Liver Disease | 0 (0%) | 1 (0.1%) | 4 (0.3%) | 1 (0.3%) | 0.737 |
DM without Chronic Complications | 37 (10.2%) | 185 (18.3%) | 353 (22.6%) | 85 (23.2%) | < 0.001 |
DM with Chronic Complications | 3 (0.8%) | 31 (3.1%) | 41 (2.6%) | 18 (4.9%) | 0.007 |
Hemiplegia/Paraplegia | 0 (0%) | 5 (0.5%) | 1 (0.1%) | 2 (0.5%) | 0.057 |
Renal Disease | 6 (1.6%) | 47 (4.6%) | 68 (4.4%) | 16 (4.4%) | 0.056 |
Malignancy: Leukemia/Lymphoma | 57 (15.7%) | 126 (12.5%) | 150 (9.6%) | 32 (8.7%) | 0.002 |
Malignancy: Solid Tumor | 20 (5.5%) | 39 (3.9%) | 38 (2.4%) | 9 (2.5%) | 0.013 |
HIV/AIDS | 3 (0.8%) | 16 (1.6%) | 14 (0.9%) | 2 (0.5%) | 0.307 |